Analysts/Institutional Investor Meet/Con. Call Updates

i INDO BORAX & CHEMICALS-LTD. Regd. Office: 506. 5th Floor. Tulsiani Chambers. Free Press Journal Marg, Nariman Point, Mumbai - 400021, India. Ph.: 022 35218591 • CIN: L24100MH1980PLC023177 Email : info(i:1 indoborax.com • Website : www.indoborax.com September l, 2026 BSE Ltd, National Stock Exchange of India Ltd. Corporate Relationship Department, Listing Department, Phiroze Jeejebhoy Towers, Exchange Plaza, Dalal Street, Bandra-Kurla Complex, Mumbai - 400 001 Bandra (East), Mumbai- 400 051 Stock Code : 524342 Stock Code: INDOBORAX Dear Sir/Madam, Sub: Intimation of Investor Presentation for the quarter ended June 30, 2026 This is in continuation to our letter dated August 27, 2026 wherein we had informed regarding an Earnings Call scheduled with Analysts/ Investors on Wednesday, September 02, 2026 at 4:00 p.m. (IST) to discuss the Unaudited (Standalone and Consolidated) Financial Results for the quarter ended June 30, 2026. Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith the Investor Presentation for the said Earnings Call. We request you to kindly take the same on record. Thanking you, For Indo Borax & Chemicals Limited Pravin Chavan Company Secretary & Compliance Officer M. No. A16857 Encl: As above llndo1 B,orax 1& Cllemi:cals L.td .. INDO BORAX & CHEMICALS LIMITED INVESTOR PRESENTATION Q1 FY27 Disclaimer lndo Borax & Chemicals Ltd. This presentation has been prepared by Indo Borax Chemicals Limited (the “Company” or “Indo Borax” ) solely for information purposes and does not constitute any offer, recommendation or invitation to purchase or subscribe for any securities, and shall not form the basis or be relied on in connection with any contract or binding commitment whatsoever. No offering of securities of the Company will be made except by means of a statutory offering document containing detailed information about the Company. This Presentation has been prepared by the Company based on information and data which the Company considers reliable, but the Company makes no representation or warranty, express or implied. This Presentation may not be all inclusive and may not contain all of the information that you may consider material. Any liability in respect of the contents of, or any omission from, this Presentation is expressly excluded. Certain matters discussed in this Presentation may contain statements regarding the Company’s market opportunity and business prospects that are individually and collectively forward-looking statements. Such forward-looking statements are not guarantees of future performance and are subject to known and unknown risks, uncertainties and assumptions that are difficult to predict. These risks and uncertainties include, but are not limited to, the performance of the Indian economy and of the economies of various international markets, the performance of the industry in India and world-wide, competition, the company’s ability to successfully implement its strategy, the Company’s future levels of growth and expansion, technological implementation, changes and advancements, changes in revenue, income or cash flows, the Company’s market preferences and its exposure to market risks, as well as other risks. The Company’s actual results, levels of activity, performance or achievements could differ materially and adversely from results expressed in or implied by this Presentation. The Company assumes no obligation to update any forward-looking information contained in this Presentation. Any forward-looking statements and projections made by third parties included in this Presentation are not adopted by the Company and the Company is not responsible for such third party statements and projections. IINNVVEESSTTOORR PPRREESSEENNTTAATTIIOONN 22 Executive Summary lndo Borax & Chemicals Ltd . Established in 1980, carrying Established customer & legacy of over 45 years distributor relationships across decades Leading player of Boric Acid in India, with market share Established leader with a of ~50% premium brand The sole manufacturer of IP Boric ac\<i grade Boric Acid in the Q1FY27 (Consolidated) • country with a valid FDA Revenue: Rs. 70.36 Cr license & BIS license EBITDA: Rs. 19.80 Cr PAT: Rs. 16.25 Cr State-of-the-Art facility at Pithampur, MP, with in- house technology • Indo Borax & Chemicals Limited, was among the pioneers in boric acid production in India Production Capacity • • Now, a leading player in Boric Acid with large Boric Acid : 20,000 MTPA capacity producing quality products, - and DOT : 6,000 MTPA diversified in Disodium Octaborate Tetrahydrate (DoT). IINNVVEESSTTOORR PPRREESSEENNTTAATTIIOONN 3 Q1 FY27 Financial Performance Boric acid Quarterly Performance Highlights lndo Borax & Chemicals Ltd. Revenue (In Rs. Cr) EBITDA (In Rs. Cr) PAT (In Rs. Cr) 80.00 70.36 63.01 25.00 18.00 16.25 70.00 19.8 14.53 16.00 53.57 60.00 20.00 14.00 50.00 12.00 10.20 12.82 15.00 12.21 40.00 10.00 8.00 30.00 10.00 6.00 20.00 5.00 4.00 10.00 2.00 0.00 0.00 0.00 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Q1FY26 Q4FY26 Q1FY27 Performance Highlights 1. Consolidated operating revenue grew by 31.34% YoY to Rs. 70.36 Cr 2. EBITDA increased by 62.16% YoY to Rs. 19.80 Cr, with margin increased at 28.14% 3. Net profit rose by 59.31% YoY to Rs. 16.25 Cr; EPS stood at Rs. 5.07 4. Strong performance driven by improved capacity utilization, operational efficiencies, and higher realizations 5. Steady domestic demand and efficient execution supported overall growth during the quarter INVESTOR PRESENTATION 5 FY26 vs. FY25 Performance Highlights lndo Borax & Chemicals Ltd. Revenue (In Rs. Cr) EBITDA (In Rs. Cr) PAT (In Rs. Cr) 250.00 215.45 50.00 45.89 55.00 50.27 44.16 200.00 175.26 45.00 50.00 42.51 150.00 40.00 45.00 35.00 40.00 100.00 30.00 35.00 50.00 25.00 30.00 0.00 20.00 25.00 FY25 FY26 FY25 FY26 FY25 FY26 Performance Highlights 1. Consolidated operating revenue increased by 22.9% YoY to Rs. 215.45 Cr 2. PAT grew by 18.3% YoY to Rs. 50.27 Cr, while EPS increased to Rs. 15.67 3. Healthy profitability maintained with EBITDA margin of 20.5% and PAT margin of 21.8% during FY26 4. Improved plant balancing initiatives enhanced capacity utilization and supported demand growth INVESTOR PRESENTATION 6 Management Commentary Mr. Suresh Kalra Managing Director & CEO “The strong performance during the first quarter of this financial year has been driven by higher capacity utilization, better realizations, strategic expansion initiatives undertaken and steady demand across domestic markets. Our continued focus on fiscal discipline, operational excellence, and value creation enabled us to maintain healthy profitability and a strong balance sheet . The Board has also approved the amalgamation of its wholly owned subsidiary – Indoborax Infrastructure Pvt. Ltd., and the acquisition of 64.26% equity shares of Kronox Lab sciences- which will help create greater efficiency , larger reach and more effective utilization of the combined resources. Going forward, we remain optimistic about the opportunities emerging from the ‘Aatmanirbhar Bharat’ and ‘Make in India’ initiatives. With a credible team, efficient manufacturing capabilities, strong industry positioning , we are confident of delivering sustainable growth and long-term value to all stakeholders.” INVESTOR PRESENTATION 77 Post Q1 FY27 Developments lndo Borax & Chemicals Ltd. Post Quarter Developments - The Board of Directors approved the Scheme of Amalgamation of Wholly Owned Subsidiary of the company, Indoborax Infrastructure Private Limited, with Indo Borax & Chemicals Ltd. • The proposed amalgamation will help create greater efficiency and more effective utilisation of the combined resources and will also create concentrated management focus besides streamlining governance and facilitating faster decision making. The Board of Directors approved the acquisition o [Showing first 8,000 characters — download PDF for full document]